PATENT CLAIM ANALYSIS

Application Number: 16028858
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "033000"]

Abstract:
The present disclosure relates to treatment of a pulmonary disease. The methods and kits provided herein facilitate relieving the symptoms resulting from the pulmonary disease (e.g., asthma, chronic obstructive pulmonary disease (COPD), etc.).

Claim (Index 7):
The method of  claim 1 , wherein the isolated compound of formula (I) is selected from the group consisting of kudinoside A, kudinoside B, kudinoside C, kudinoside D, kudinoside E, kudinoside F, kudinoside I, kudinoside J, Ilekudinoside H, Ilekudinoside I, and Ilekudinoside J.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 95.0
- Lexical Diversity: 1.3871
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15129965', '14366218', '12312749', '12596068', '13471111']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7736096815758648
- 35 USC 102 Novelty (BERT): 0.6356415532458931
- Combined Prediction Score: 0.7598128687428678
- Mean Citation Score: 298.657284
- Max Citation Score: 705.1274400000003
- Similarity Product: 529.8103947530939

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test